Pharmacogenetically determined treatment' influence Left Ventricular Mass Index (LVMI) in relation to polymorphisms of ACE, AGTR1, eNOS, PPAR-G2, ADRB1 genes in essential hypertensive (EAH) patients
JavaScript is disabled for your browser. Some features of this site may not work without it.
Pharmacogenetically determined treatment' influence Left Ventricular Mass Index (LVMI) in relation to polymorphisms of ACE, AGTR1, eNOS, PPAR-G2, ADRB1 genes in essential hypertensive (EAH) patients
Sydorchuk, L.; Amosova, K.M.; Sydorchuk, R.; Ursuliak, U.; Sydorchuk, I.